Stay updated on Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page.

Latest updates to the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page
- Check7 days agoChange DetectedAdded Contacts/Locations and Study Status sections in the version history, updating the record with current recruitment status and location details. The revision is v3.5.2.SummaryDifference0.4%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedAdded Revision: v3.5.0 to the history and removed Revision: v3.4.3.SummaryDifference0.1%

- Check43 days agoChange DetectedA new revision entry (v3.4.3) was added to the history, replacing the previous entry (v3.4.2).SummaryDifference0.1%

- Check71 days agoChange DetectedThe history shows a new site revision, v3.4.2, replacing the previous v3.4.1 notice about government funding and operating status. The old funding-status notice has been removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check78 days agoChange DetectedAdded a site-wide notice about government funding and updated the revision to v3.4.1. Removed the previous revision entry v3.4.0.SummaryDifference0.5%

- Check85 days agoChange DetectedNew UI elements are added: a glossary toggle and color-coded indicators for additions and deletions in the record history. The revision label updates from v3.3.4 to v3.4.0 and a No FEAR Act Data line is now shown.SummaryDifference0.7%

Stay in the know with updates to Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page.